— Know what they know.
Not Investment Advice
Also trades as: POXEL.PA (PAR) · $vol 0M · 0RA2.L (LSE) · $vol 0M

PXXLF OTC

Poxel S.A.
1W: +0.0% 1M: -15.4% 3M: -15.4% YTD: -15.4% 1Y: -12.0% 3Y: -96.7% 5Y: -96.8%
$0.22
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Strong Sell · Power 33 · $13.7M mcap · 42M float · 0.0002% daily turnover

Income Trends

Revenue
$7M +246.8% ▲
5Y CAGR: -23.7%
Gross Profit
$4M +382206.7% ▲
5Y CAGR: -32.1%
Operating Income
-$4M +84.4% ▲
Net Income
-$19M +46.0% ▲
EPS (Diluted)
$-0.44 +51.6% ▲
EBITDA
-$4M +63.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$7M$13M$674K$2M$7M
YoY Growth-74.4%+96.8%-95.0%+193.9%+246.8%
Cost of Revenue$551K$59K$672K$2M$3M
Gross Profit$6M$13M$2K$1K$4M
Gross Margin91.9%99.6%0.3%0.1%55.7%
R&D Expenses$29M$27M$14M$21M$2M
SG&A Expenses$10M$11M$4M$5M$7M
Operating Expenses$37M$36M$22M$29M$8M
Operating Income-$30M-$22M-$22M-$29M-$4M
Operating Margin-438.5%-167.7%-3247.8%-1452.0%-65.4%
Interest Expense$2M$3M$4M$6M$15M
Income Before Tax-$32M-$24M-$31M-$35M-$20M
Tax Expense$36K$2K$2K$2K-$868K
Net Income-$32M-$24M-$31M-$35M-$19M
Net Margin-468.1%-177.4%-4658.5%-1771.3%-275.8%
EPS (Diluted)$-1.16$-0.83$-1.08$-0.91$-0.44
EBITDA-$30M-$21M-$27M-$12M-$4M
Shares Outstanding28M29M29M39M43M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms